Recent Developments in Drug-Eluting Coronary Stents

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 14, Iss. 3, 2014-12 ,pp. : 220-224

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Drug-eluting Stents and Concomitant Treatment)

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 14, Iss. 3, 2014-12 ,pp. : 219-219

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Eluting Stents in Interventional Cardiology - Current Evidence and Emerging Uses

By  

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, Iss. 4, 2005-08 ,pp. : 313-321

Bentham Science Publishers

Access to resources Recommend Favorite

Current Understanding of In-stent Restenosis and the Potential Benefit of Drug Eluting Stents

By  

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 4, Iss. 1, 2004-03 ,pp. : 103-117

Bentham Science Publishers

Access to resources Recommend Favorite

Tumor Necrosis Factor-α Antibody Eluting Stents Reduce Vascular Smooth Muscle Cell Proliferation in Saphenous Vein Organ Culture

By Javed Q.   Swanson N.   Vohra H.   Thurston H.   Gershlick A.H.  

Experimental and Molecular Pathology, Vol. 73, Iss. 2, 2002-10 ,pp. : 104-111

Academic Press

Access to resources Recommend Favorite